As someone with severe allergies, she saw that EpiPens and other needle injections were the only ways for schools to administer the lifesaving medication epinephrine, which is used to slow allergic ...

The FDA has approved Dupixent (dupilumab) for the treatment of adult and pediatric patients aged 6 years and older with allergic fungal rhinosinusitis.

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitisApproval in adults and ...

Stanford Medicine researchers have developed an experimental nasal vaccine that shielded mouse lungs for at least three months against a striking range of respiratory threats, from SARS-CoV-2 and ...

In a phase 2 trial, patients having an urticaria exacerbation who used the spray report better hive and pruritus scores than ...

A Stanford University School of Medicine research team has developed a vaccine technology that can prevent respiratory ...

Stanford Medicine researchers claim they've created a "universal" that can protect against a viruses ranging from COVID to ...

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are ...

Intranasal boosting after prior intramuscular COVID vaccination induced strong mucosal IgA responses in a small human cohort. These antibodies showed markedly enhanced neutralising activity against ...

Nasal drops eliminated the deadliest brain cancer in mice and activated long-lasting immune defenses that prevented the return of tumors ...

Neffy needle-free epinephrine spray sales surge, global expansion, and CSU Phase 2b upside. See more on SPRY here.

The Oregon Senate has unanimously passed Senate Bill 1504, aiming to enhance emergency response to allergic reactions in ...